PTD-DBM: A Cell-Penetrating Peptide in Tissue-Regeneration Research
PTD-DBM is a synthetic peptide combining a protein transduction domain (PTD), which enhances cell-membrane penetration, with a bone-morphogenetic-protein-derived motif. It is studied for its role in osteoblast differentiation and tissue-regeneration models.
What is PTD-DBM?
The peptide is designed to mimic bone morphogenetic protein (BMP) signaling while the PTD portion improves intracellular delivery across cell membranes. This combination makes it a research tool for studying regenerative signaling pathways at the cellular level.
Mechanism in research models
PTD-DBM is studied for stimulating osteoblast differentiation, osteoblasts being the cells responsible for bone formation. By engaging cellular receptors, it can trigger signaling cascades associated with bone growth and tissue repair in preclinical models.
Research areas
- Bone-regeneration models: fracture and bone-defect repair studies.
- Dental research: bone-growth models around implants and periodontal tissue.
- Soft-tissue repair: wound-healing model investigations.
- Orthopedic research: bone-fusion model studies.
Handling for regional research labs
- Not authorized by Health Southeast Asia for human use, laboratory research only. Much of the evidence is early-stage (animal models).
- Store lyophilized at −20°C; reconstitute with sterile bacteriostatic water using aseptic technique.
- Source from reputable suppliers providing third-party purity testing and a COA.
Explore related tissue-repair research compounds we carry: BPC-157, TB-500, and GHK-Cu, all third-party tested to over 99% purity with a COA. Pair with bacteriostatic water.
This guide is part of our Peptides Southeast Asia research hub, explore the full library of compound guides.
Disclaimer: Educational and research content only. PTD-DBM is discussed strictly as a research chemical, not for human consumption or therapeutic use. All work must comply with regional regulations and institutional ethics approvals.
